Angela P Dominique, DPM | |
3524 Decatur Hwy, Suite 301, Fultondale, AL 35068-1366 | |
(205) 631-3699 | |
(205) 631-7325 |
Full Name | Angela P Dominique |
---|---|
Gender | Female |
Speciality | Podiatrist |
Location | 3524 Decatur Hwy, Fultondale, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508972563 | NPI | - | NPPES |
480026565 | Other | AL | RAILROAD MEDICARE |
000060837 | Medicaid | AL | |
27-10123 | Other | AL | UNITED HEALTHCARE |
1536404 | Other | AL | UMWA H&R FUNDS |
U71228 | Other | AL | VIVA HEALTH |
510-60837 | Other | AL | BLUE CROSS BLUE SHIELD AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 180 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Angela P Dominique, DPM 3524 Decatur Hwy, Suite 301, Fultondale, AL 35068-1366 Ph: (205) 631-3699 | Angela P Dominique, DPM 3524 Decatur Hwy, Suite 301, Fultondale, AL 35068-1366 Ph: (205) 631-3699 |
News Archive
Patients with diabetes who follow a self-care regimen generally have success in controlling their disease. But what about patients whose other health conditions, such as cognitive impairment and/or depression, create barriers to effective treatment?
Septic shock is a severe systemic infection and major cause of death for the old and young alike. Unfortunately, researchers say testing new drug regimens to stop the infection is confounded because clinical trials include patients who are either too sick to be saved by experimental therapies or not sick enough to warrant the treatments.
More time spent intensely active, to a greater extent than less time spent sedentary, correlates with a healthier metabolic profile in adolescence, according to a study published this week in PLOS Medicine.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
Scientists at deCODE genetics and academic colleagues from the Netherlands and twelve other countries across Europe and North America today report the discovery of a common single-letter variation (SNP) in the sequence of the human genome conferring risk of a range of vascular diseases. The SNP confers risk of abdominal aortic aneurysm (AAA), early-onset heart attack, peripheral artery disease (PAD), and pulmonary embolism, independent of other known risk factors.
› Verified 6 days ago